Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Debt-laden Valeant Sells Its Assets, More Divestments Likely

Jan 10 2017

• By Sten Stovall

Currency

Related Content

Valeant's New Strategic Direction: Clean Break Or Simply A Paint Job?

Aug 10 2016

Valeant: Another Fine Mess

Mar 02 2016

Valeant ups bid for Dendreon's Provenge to $400m

Feb 06 2015

Related Companies

Bausch Health Companies Inc.

L'Oreal SA

Dendreon Corporation

Salix Pharmaceuticals Ltd.

Takeda Pharmaceutical Co. Ltd.

Additional Topics

Commercial Companies Deals Legal Issues M & A BioPharmaceutical

More from Business

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window